We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Liquid Biopsies – Multimedia

App Note / Case Study

A Complete NGS Workflow for Circulating cfDNA Isolation and Analysis

Download this application note for advice on optimizing your NGS workflow, the benefits this brings to cancer research and how established methods can obtain more information more quickly.
Circulating Tumor Cells (CTCs): Tracking the Spread of Cancer content piece image
Video

Tracking Cancer on the Move: Finding That One in a Million

An analogy of finding CTCs: Imagine you have three friends, and they are somewhere in Canada. But you don't know where they are. Also, they change their clothes and hair colour every day.
Watch to learn about this liquid biopsy test that has successfully progressed from the research lab to the clinic.
Precision Medicine and Liquid Biopsy: The Future of Diagnosing and Managing Disease content piece image
Video

Precision Medicine and Liquid Biopsy: The Future of Diagnosing and Managing Disease

Dr. Jeffrey Trent and Dr. Muhammad Murtaza of TGen, an affiliate of City of Hope, discuss the significance of liquid biopsies in the diagnoses and management of life-threatening diseases.
6 Microfluidic Researchers You Should Follow content piece image
Listicle

6 Microfluidic Researchers You Should Follow

In this list we take a look at 6 researchers whose contributions have helped (and are continuing to help) drive the field forward.
Eight Emerging Applications of Mass Spectrometry content piece image
Listicle

Eight Emerging Applications of Mass Spectrometry

This article highlights some of the wide range of applications which can be achieved using mass spectrometry.
Is Oxford Nanopore Technology Ready for Clinical Diagnostics? content piece image
Poster

Is Oxford Nanopore Technology Ready for Clinical Diagnostics?

Our objective is to validate diagnostic services using Oxford Nanopore’s Minion in the first instance and to evaluate the cost and performance compared to existing sequencing technology in areas such as tumour DNA sequencing (and circulating tumour DNA), virology, microbiology, genetics and HLA-typing.
A Novel Cell-Free DNA Extraction System for Cancer Diagnostics content piece image
Poster

A Novel Cell-Free DNA Extraction System for Cancer Diagnostics

We developed a magnetic bead-based cfDNA extraction kit and integrated it into the automated qPCR- and NGS-based IVD workflows. In this study we are compering this magnetic beads-based cfDNA extraction system with a column-based method.
Clinical Applications of “Liquid Biopsy” in the Colorectal Cancer Treatment content piece image
Poster

Clinical Applications of “Liquid Biopsy” in the Colorectal Cancer Treatment

Liquid biopsy provides a circulating biomarker not only for treatment response but decision making of a sequential strategy.
Video

Tissue and cfDNA Rare Alleles How Low Can We Go

Seth Crosby, Washington University School of Medicine, discusses both bench and informatic methods used to increase specificity in the apprehension of rare cfDNA alleles.
Video

Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test

Jeff Cummings presents a worked example of circulating tumour cell enumeration as a prognostic/predictive biomarker in cancer research.
Advertisement